Trials / Unknown
UnknownNCT04999553
Left vs. Right Non-Inferiority Trial
Left Intermittent Theta Burst Stimulation vs. Right Low Frequency Repetitive Transcranial Magnetic Stimulation Effectiveness in Depression and Suicidal Ideation: A Randomized Non-Inferiority Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to test the hypothesis that low-frequency rTMS (LFR) works as well as the established intermittent thetaburst rTMS (iTBS) treatment for treatment resistant depression (TRD).
Detailed description
In this multi-centre, triple-blinded, non-inferiority trial 420 patients with TRD will be recruited at two academic centres (UBC, CAMH). Patients will be randomised to receive either iTBS or LFR for 30 sessions. The primary outcome will be the improvement on a depression scale. Secondary outcome will be improvement of suicidal ideation. A secondary aim is to test the predictive capacity of a novel, easy to implement heart rate based biomarkers (i.e. heart rate variability).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Repetitive Transcranial Magnetic Stimulation | rTMS will employ the MagPro X100/R30 stimulator equipped with the cool-B70 as we used a cool-B70 in our past non-inferiority trial. The dose will be a 120% rMT in accordance to our latest trial using iTBS. The target area to stimulate will be the right dorsolateral prefrontal cortex (DLPFC) for LFR and the left DLPFC for iTBS as established in prior clinical trials. The localization of both targets will follow the well-established procedures for either R-DLPFC or L-DLPFC using a heuristic method. |
| DEVICE | Intermittent Theta Burst Stimulation (iTBS) | Intermittent Theta Burst Stimulation (iTBS) |
| DEVICE | Low Frequency Right (LFR) | Low Frequency Right (LFR) |
Timeline
- Start date
- 2021-11-08
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2021-08-11
- Last updated
- 2021-11-10
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04999553. Inclusion in this directory is not an endorsement.